Filters

2020 - 20234

More filters

2021 - 20244
Reset filters

Settings

Author: Yang, Li ×

Search Results

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    When Ultimate Adhesive Mechanism Meets Ultimate Anti‐Fouling Surfaces - Polydopamine Versus SLIPS: Which One Prevails?
    (Weinheim : Wiley-VCH, 2020) Prieto-López, Lizbeth Ofelia; Herbeck-Engel, Petra; Yang, Li; Wu, Qian; Li, Juntang; Cui, Jiaxi
    What happens when the extremely adhesive and versatile chemistry of polydopamine (PDA) is in contact with the extremely slippery surfaces known as slippery liquid‐infused porous substrates (SLIPS)? Inspired by the pitcher plant, SLIPS possess excellent repellence against a variety of complex liquids and have been proposed as promising antifouling surfaces because of their successful performance even in marine environments. In the counterpart, inspired by the adhesive proteins enabling the strong adhesion of mussels to multiple substrates, PDA has been extensively studied for its ability to adhere on nearly every type of substrate. The interaction between various SLIPS systems and the highly fouling medium from the oxidative polymerization of dopamine is explored here. A PDA coating is observed on all the SLIPS evaluated, modifying their hydrophobicity in most cases. In‐depth study of silicone‐based SLIPS shows that hydrophobicity of PDA coated SLIPS partially recovers with time due to percolation of the lubricant through the coating. “Strongly” bound PDA species are attributed to the formation of dopamine‐polydimethylsiloxane species on the crosslinked matrix, rendering a coating that withstands repeated washing steps in various solvents including water, hexane, and toluene. The results not only satisfy scientific curiosity but also imply a strategy to modify/bond SLIPS.
  • Thumbnail Image
    Item
    Reversibly growing crosslinked polymers with programmable sizes and properties
    ([London] : Nature Publishing Group UK, 2023) Zhou, Xiaozhuang; Zheng, Yijun; Zhang, Haohui; Yang, Li; Cui, Yubo; Krishnan, Baiju P.; Dong, Shihua; Aizenberg, Michael; Xiong, Xinhong; Hu, Yuhang; Aizenberg, Joanna; Cui, Jiaxi
    Growth constitutes a powerful method to post-modulate materials’ structures and functions without compromising their mechanical performance for sustainable use, but the process is irreversible. To address this issue, we here report a growing-degrowing strategy that enables thermosetting materials to either absorb or release components for continuously changing their sizes, shapes, compositions, and a set of properties simultaneously. The strategy is based on the monomer-polymer equilibrium of networks in which supplying or removing small polymerizable components would drive the networks toward expansion or contraction. Using acid-catalyzed equilibration of siloxane as an example, we demonstrate that the size and mechanical properties of the resulting silicone materials can be significantly or finely tuned in both directions of growth and decomposition. The equilibration can be turned off to yield stable products or reactivated again. During the degrowing-growing circle, material structures are selectively varied either uniformly or heterogeneously, by the availability of fillers. Our strategy endows the materials with many appealing capabilities including environment adaptivity, self-healing, and switchability of surface morphologies, shapes, and optical properties. Since monomer-polymer equilibration exists in many polymers, we envision the expansion of the presented strategy to various systems for many applications.
  • Thumbnail Image
    Item
    A thrombin-triggered self-regulating anticoagulant strategy combined with anti-inflammatory capacity for blood-contacting implants
    (Washington, DC [u.a.] : Assoc., 2022) Wang, Yanan; Wu, Haoshuang; Zhou, Zhongyi; Maitz, Manfred F.; Liu, Kunpeng; Zhang, Bo; Yang, Li; Luo, Rifang; Wang, Yunbing
    Interrelated coagulation and inflammation are impediments to endothelialization, a prerequisite for the longterm function of cardiovascular materials. Here, we proposed a self-regulating anticoagulant coating strategy combined with anti-inflammatory capacity, which consisted of thrombin-responsive nanogels with anticoagulant and anti-inflammatory components. As an anticoagulant, rivaroxaban was encapsulated in nanogels cross-linked by thrombin-cleavable peptide and released upon the trigger of environmental thrombin, blocking the further coagulation cascade. The superoxide dismutase mimetic Tempol imparted the antioxidant property. Polyphenol epigallocatechin gallate (EGCG), in addition to its anti-inflammatory function in synergy with Tempol, also acted as a weak cross-linker to stabilize the coating. The effectiveness and versatility of this coating were validated using two typical cardiovascular devices as models, biological valves and vascular stents. It was demonstrated that the coating worked as a precise strategy to resist coagulation and inflammation, escorted reendothelialization on the cardiovascular devices, and provided a new perspective for designing endothelium-like functional coatings.
  • Thumbnail Image
    Item
    Platelet Membrane-Coated Nanocarriers Targeting Plaques to Deliver Anti-CD47 Antibody for Atherosclerotic Therapy
    ([Beijing] : China Association for Science and Technology, 2022) Chen, Liang; Zhou, Zhongyi; Hu, Cheng; Maitz, Manfred F.; Yang, Li; Luo, Rifang; Wang, Yunbing
    Atherosclerosis, the principle cause of cardiovascular disease (CVD) worldwide, is mainly characterized by the pathological accumulation of diseased vascular cells and apoptotic cellular debris. Atherogenesis is associated with the upregulation of CD47, a key antiphagocytic molecule that is known to render malignant cells resistant to programmed cell removal, or "efferocytosis." Here, we have developed platelet membrane-coated mesoporous silicon nanoparticles (PMSN) as a drug delivery system to target atherosclerotic plaques with the delivery of an anti-CD47 antibody. Briefly, the cell membrane coat prolonged the circulation of the particles by evading the immune recognition and provided an affinity to plaques and atherosclerotic sites. The anti-CD47 antibody then normalized the clearance of diseased vascular tissue and further ameliorated atherosclerosis by blocking CD47. In an atherosclerosis model established in ApoE-/- mice, PMSN encapsulating anti-CD47 antibody delivery significantly promoted the efferocytosis of necrotic cells in plaques. Clearing the necrotic cells greatly reduced the atherosclerotic plaque area and stabilized the plaques reducing the risk of plaque rupture and advanced thrombosis. Overall, this study demonstrated the therapeutic advantages of PMSN encapsulating anti-CD47 antibodies for atherosclerosis therapy, which holds considerable promise as a new targeted drug delivery platform for efficient therapy of atherosclerosis.